Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

VA Contract Update

10 May 2013 07:00

RNS Number : 3944E
Ideagen PLC
10 May 2013
 



 

Ideagen PLC

("Ideagen" or the "Company")

 

VA Contract Update

 

Ideagen PLC (AIM: IDEA), a leading supplier of Compliance based Information Management solutions, announces that the Company has received notification from the US Department of Veterans Affairs (VA) to 'terminate for convenience' year two of the Prism contract expected to complete during November 2013. The cancellation of this contract has no effect on market expectations for the current financial year.

 

As notified in the announcement of 29 November 2012, approximately 70% of the anticipated revenue from year two of the contract of approximately ÂŁ1.05 million was recognised in the financial period ending 30 April 2013. Given the current nature of the US Federal budgets the Company had made ample contingency within its business plan to ensure that in the event of this programme discontinuing following the second year of the contract there would be no impact on the current market expectations for the financial period ending 30 April 2014. The Company therefore remains confident in meeting market expectations for the financial period ending 30 April 2014.

 

The decision to terminate year two of the Prism contract was made for budgetary reasons and the Company remains a trusted and important supplier to the VA and will continue to support the existing deployment of Proquis Enterprise™ at 40 VA hospitals across the USA and to market its products to VA hospitals at a local and regional level.

 

The notice to 'terminate for convenience' the Company's Prism contract is a no fault termination right held by the US Government over all Federal Contracts and, as the Company has complied fully with all commercial and technical contractual obligations, it is entitled to a settlement under Federal Acquisition Regulation (FAR) 52.2124 (i) in respect of the second year of the contract to November 2013. The VA has requested a proposal for settlement from the Company which will be submitted as soon as possible.

 

David Hornsby, Chief Executive of Ideagen, commented, "Whilst we are disappointed that year two of the Prism contract has been terminated, I am pleased to report our budgetary processes were robust. The business continues to trade strongly and the Company remains confident of delivering further revenue and profit growth in the current financial period."

 

Enquiries:

 

 

Ideagen Plc

 

Tel: 01629 761590

David Hornsby, Chief Executive

 

 

Graeme Spenceley, Finance Director

 

 

 

 

 

finnCap (Nominated Adviser and Broker)

 

Tel: 020 7220 0500

Matt Goode/Charlotte Stranner (Corporate Finance)

 

 

Stephen Norcross (Corporate Broking)

 

 

 

 

 

Walbrook PR Ltd

 

Tel: 020 7933 8780

Helen Westaway

 

Helen.westaway@walbrookpr.com

Paul Cornelius

 

Paul.cornelius@walbrookpr.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAPSNEFKDEFF
Date   Source Headline
12th Nov 20207:00 amRNSPre-Close Trading Update and Board Changes
5th Nov 202010:46 amRNSPDMR Shareholding and Exercise of Options
4th Nov 20202:30 pmRNSHolding(s) in Company
29th Oct 202011:28 amRNSHolding(s) in Company
28th Oct 20203:59 pmRNSResult of AGM
21st Oct 20202:59 pmRNSHolding(s) in Company
16th Oct 202012:44 pmRNSExercise of share options and Total Voting Rights
14th Oct 20207:00 amRNSIssue of Equity and Total Voting Rights
5th Oct 20202:19 pmRNSNotice of AGM
2nd Oct 20201:52 pmRNSHolding(s) in Company
1st Oct 20208:28 amRNSPDMR Dealing and Exercise of Options
29th Sep 20205:51 pmRNSIssue of New Shares
22nd Sep 20207:00 amRNSFinal Results
15th Sep 20203:10 pmRNSHolding(s) in Company
24th Aug 20202:36 pmRNSHolding(s) in Company
19th Aug 20203:55 pmRNSIssue of New Shares
10th Aug 20207:00 amRNSTrading Update and Acquisition of Qualsys Ltd
14th Jul 20208:44 amRNSExercise of Options and TVR
1st Jul 20207:00 amRNSBoard Changes
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:36 pmRNSPrice Monitoring Extension
22nd Jun 20207:00 amRNSExercise of Options and Total Voting Rights
16th Jun 20207:00 amRNSExercise of Options and TVR
26th May 20208:30 amRNSExercise of Options and TVR
22nd May 20207:00 amRNSPartnership with the World Health Organisation
21st May 20201:06 pmRNSHolding(s) in Company
19th May 20207:00 amRNSPre-Close Trading Update
28th Apr 20202:26 pmRNSExercise of Options and TVR
22nd Apr 20207:00 amRNSIssue of New Shares, Director Dealings and TVR
9th Apr 20207:00 amRNSExercise of Options and TVR
7th Apr 20207:00 amRNSCOVID-19 Trading Update
30th Mar 20207:00 amRNSIssue of new shares under SIP and TVR
6th Mar 20207:00 amRNSAcquisition of Workrite Ltd
25th Feb 202011:09 amRNSIssue of Equity
27th Jan 20204:56 pmRNSExercise of Options and TVR
22nd Jan 20207:00 amRNSInterim Results
20th Jan 20205:10 pmRNSIssue of Equity under Share Incentive Plan
7th Jan 20207:00 amRNSBoard Change
17th Dec 20194:08 pmRNSIssue of Equity
13th Dec 20194:38 pmRNSDirector/PDMR Shareholding
3rd Dec 20192:44 pmRNSHolding(s) in Company
2nd Dec 201911:29 amRNSPDMR Dealing and Total Voting Rights
29th Nov 20199:57 amRNSHolding(s) in Company
21st Nov 20194:06 pmRNSHolding(s) in Company
20th Nov 201911:58 amRNSDirector/PDMR Dealings and Total Voting Rights
18th Nov 20192:00 pmRNSIssue of Shares under Share Incentive Plan
13th Nov 20197:00 amRNSTrading Update
30th Oct 20193:48 pmRNSResult of AGM
24th Oct 20197:00 amRNSBoard Change
23rd Oct 201911:45 amRNSShare Incentive Plan and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.